Home LiteratureArticle Details
PMID: 2837137 Published · ppublish English Comparative Study Journal Article

Early stages of in vitro killing curve of LY146032 and vancomycin for Staphylococcus aureus.

Antimicrobial agents and chemotherapy ·Vol. 32 ·No. 4 ·1988-04-00 ·Pages 454-7

Flandrois JP, Fardel G, Carret G

Abstract

The early stages of the time-killing curves of vancomycin and LY146032 have been studied, by use of short sampling intervals, for three strains of Staphylococcus aureus. Both vancomycin and LY146032 killed S. aureus, but the time-killing curves differed: the effect of vancomycin was slow, limited, and not related to the concentration of the drug, whereas that of LY146032 was rapid, extensive, and related to concentration. When strains ATCC 25923 and CIP 6525 were exposed to LY146032, the population decreased exponentially with time. The killing rate was constant and linked to the concentration by a Michaelis-Menten relationship. The maximum killing rate and the affinity constant of LY146032, estimated from the data transformed by the Lineweaver-Burk method, differed for the two strains. The concentration of the antibiotic at which killing theoretically begins (estimated by linear regression using the logarithm of the concentration) is of the same magnitude as the MIC of LY146032, which indicates the pure bactericidal mode of action of the drug. S. aureus ATCC 12600 was more resistant to the bactericidal effect of the two drugs, and its killing curve did not conform to the model described here.

MeSH Terms
Anti-Bacterial Agents/pharmacology Daptomycin Microbial Sensitivity Tests Peptides/pharmacology Staphylococcus aureus/drug effects Vancomycin/pharmacology
Chemicals
Anti-Bacterial Agents Peptides Vancomycin Daptomycin
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Flandrois J P
Laboratoire de Bactériologie, Faculté de Médecine Lyon-Sud, Université Calude Bernard Lyon I, Pierre Bénite, France.
Fardel G
Carret G
References (9)
9 references, click to expand
  1. In vitro activity of LY146032 (daptomycin) against selected aerobic bacteria.
    Eur J Clin Microbiol. 1987 Feb;6(1):91-6 PMID: 3032612
  2. Comparative in vitro activity of LY146032 (daptomycin) against gram-positive cocci.
    Eur J Clin Microbiol. 1987 Feb;6(1):96-9 PMID: 3032613
  3. In vitro activity of a new cyclic lipopeptide antibiotic, LY146032, against gram-positive clinical bacteria.
    Antimicrob Agents Chemother. 1987 Mar;31(3):455-7 PMID: 3034145
  4. Correlation between "methicillin resistance" and serotype in Staphylococcus.
    Nature. 1967 Mar 18;213(5081):1137 PMID: 5182388
  5. In vitro activity of LY146032 (daptomycin), a new peptolide.
    Eur J Clin Microbiol. 1987 Feb;6(1):84-90 PMID: 3032611
  6. In vitro activity of combinations of antibiotics against Staphylococcus aureus resistant to gentamicin and methicillin.
    Infection. 1985 Jan-Feb;13(1):35-8 PMID: 3845915
  7. In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibiotic.
    Antimicrob Agents Chemother. 1985 Mar;27(3):357-62 PMID: 3994349
  8. In vitro activity of LY146032, a new lipopeptide antibiotic, against gram-positive cocci.
    Antimicrob Agents Chemother. 1987 Feb;31(2):340-2 PMID: 3032099
  9. In vitro activity of teichomycin against isolates of gram-positive bacteria.
    Chemotherapy. 1983;29(4):275-82 PMID: 6223793
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
1988-04-00
Pages
454-7
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC172200
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com